Akili Shares Are Trading Higher After the Company Announced That Its Japanese Partner, Shionogi & Co. Ltd, Has Submitted Akili's Digital Therapeutic SDT-001 for Marketing Approval With the Ministry of Health, Labor, and Welfare
在Akili宣佈其日本合作伙伴Shionogi & Co.之後,該公司股價走高。Ltd,已將 Akili 的數字療法 SDT-001 提交衛生、勞動和福利部批准上市